Simplify Logo

Full-Time

Manager – SEC Reporting

Posted on 7/1/2024

Telix Pharmaceuticals

Telix Pharmaceuticals

201-500 employees

Develops targeted radiation therapies for cancer

Biotechnology
Healthcare

Senior, Expert

Remote in USA

Category
Financial Accounting
Accounting
Required Skills
SAP Products
Requirements
  • Bachelor’s degree in accounting, finance, or a related field
  • CPA or CA certification preferred
  • 5+ years of experience in accounting or finance roles with a strong focus on SEC reporting and compliance
  • Extensive experience in preparing and filing SEC reports, including Form 10-K, Form 10-Q, and Form 8-K
  • Experience with US GAAP financial statement preparation, including reconciliations between US GAAP and IFRS
  • Proven track record of working in publicly traded companies, preferably with experience in a NASDAQ-listed company
  • Significant experience in coordinating with external auditors, particularly under PCAOB standards
  • In-depth knowledge of revenue recognition standards under both US GAAP (ASC 606) and IFRS (IFRS 15)
  • Experience in biotechnology or pharmaceutical sectors
  • Knowledge of ERP systems, particularly SAP
  • Ability to manage multiple projects and priorities in a fast-paced
Responsibilities
  • Prepare and file required reports with the SEC, such as Form 10-K, Form 10-Q, and Form 8-K
  • Produce accurate and timely financial statements including balance sheets, income statements, and cash flow statements
  • Monitor changes in accounting standards, SEC regulations, and NASDAQ listing requirements
  • Coordinate with external auditors during reviews and annual audits
  • Analyze contracts and revenue arrangements to ensure compliance with US GAAP and IFRS revenue recognition standards
  • Preparation of financial disclosures for SEC filings
  • Develop and deliver training programs on US reporting requirements, compliance procedures, and US GAAP accounting policies
  • Participate in special projects and initiatives as needed
Telix Pharmaceuticals

Telix Pharmaceuticals

View

Telix Pharmaceuticals develops and sells products aimed at improving the diagnosis and treatment of cancer and rare diseases using targeted radiation. Their products work by delivering precise radiation to affected areas, which helps in making better treatment decisions and providing personalized therapy. Unlike many other biopharmaceutical companies, Telix focuses specifically on areas such as urologic oncology, neuro-oncology, musculoskeletal oncology, and bone marrow conditioning, addressing significant unmet medical needs. The company's goal is to enhance patient care while maintaining ethical practices and environmental responsibility, ensuring that they create sustainable value for patients, shareholders, and employees.

Company Stage

Grant

Total Funding

$63.5M

Headquarters

Melbourne, Australia

Founded

2015

Growth & Insights
Headcount

6 month growth

12%

1 year growth

27%

2 year growth

90%
Simplify Jobs

Simplify's Take

What believers are saying

  • Telix's completion of the BLA submission for TLX250-CDx positions it for potential market leadership in kidney cancer imaging.
  • Positive data from the ProstACT SELECT trial for TLX591 indicates promising efficacy in prostate cancer treatment, enhancing the company's therapeutic portfolio.
  • The FDA Fast Track designation for TLX101-CDx for glioma imaging accelerates its path to market, potentially improving outcomes for brain cancer patients.

What critics are saying

  • The recent withdrawal of its IPO due to unfavorable market conditions may impact Telix's financial flexibility and investor confidence.
  • The competitive landscape in biopharmaceuticals, especially in oncology, requires continuous innovation to maintain market position.

What makes Telix Pharmaceuticals unique

  • Telix Pharmaceuticals specializes in targeted radiation therapies, setting it apart from traditional biopharmaceutical companies that may not focus on this innovative approach.
  • The company's robust global supply chain ensures the availability and delivery of its products worldwide, providing a competitive edge in distribution and accessibility.
  • Telix's commitment to sustainability and ethical practices integrates patient care and environmental responsibility into its operations, distinguishing it from competitors.
INACTIVE